• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Neurology

Cerebrovascular procedure complications linked with race/ethnic and socioeconomic factors

by2 Minute Medicine
April 3, 2014
in Neurology, Surgery
Reading Time: 2 mins read
Repeat third trimester syphilis screening may not be cost effective
Share on FacebookShare on Twitter

Image: PD 

1. Minorities and medicaid patients had significantly increased frequency of hospital acquired complications (HACs). 

2. HACs lead to significantly increased length of stays and inpatient costs.

Evidence Rating Level: 2 (Good)            

Study Rundown: Centers for Medicare and Medicaid Services (CMS) have previously identified 11 hospital acquired conditions (HACs) that lead to preventable and high cost complication outcomes. These HACs are now linked to patient care performance benchmarks and government reimbursement. Socioeconomic status (SES) and race are well-known to be associated with disparities in health outcomes. By utilizing the large NIS database of in-patient outcomes data, this study demonstrated a clear link between racial/ethnic and SES, and higher rates of HACs following cerebrovascular procedures, even after adjusting for confounders in multivariate analysis. These findings identify a population within which targeted improvements in preventable complications need to be made to reduce significant patient morbidity and mortality, as well as hospital costs. Limitations of the study are mainly due to its retrospective and database driven methodology. Databases are subject to recording error and bias, and only accounts for in-patient outcomes and do not account for out-patient complications.

Click to read the study in NEUROSURGERY

RELATED REPORTS

Peripherally inserted central catheters are associated with twice as many complications than midline catheters when used short-term

Relevant Reading: Racial and Ethnic Disparities in the Treatment of Cerebrovascular Diseases: Importance to the Practicing Neurosurgeon

In-Depth [retrospective cohort]: This study utilized the National In-patient Sample (NIS) database to look for ICD-9 codes corresponding to cerebrovascular disease conditions and identified nearly 1.3 million discharges related to cerebrovascular procedures (CVPs) from 2002 to 2010. 0.5% of all patients were noted to have had at least one HAC, but minority and medicaid patients experienced HACs at nearly double the rate of white patients. Patients with lower median incomes based off of zip code also had higher rates of HACs. Multivariate analysis adjusting for patient and hospital level-confounders revealed that black (OR = 1.44, p <0 0.1) and hispanic (OR = 1.58, p <0.01) patients had a 40-50% likelihood of having an HAC compared to white patients. Medicaid patients exhibited a similar 50% increased likelihood. Mean length of stay for patients with HACs was significantly increased (16.7 vs 4.2 days), and total hospital costs was nearly three times(~$177k) that of patients without HACs.

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

Tags: hospital acquired complication
Previous Post

Lifestyle intervention delays diabetes and reduces mortality

Next Post

Restrictive red blood cell transfusion may decrease risk of infection

RelatedReports

Surgical site anesthetic infusion may enhance analgesia after mastectomy
Emergency

Peripherally inserted central catheters are associated with twice as many complications than midline catheters when used short-term

December 2, 2021
Next Post
New genetic link in pulmonary arterial hypertension holds therapeutic promise

Restrictive red blood cell transfusion may decrease risk of infection

Systemic beta-blockers and nitrates linked to lower intraocular pressure

HLA-DRB1*07:01 confirmed as risk factor for lapatinib-induced liver damage

HLA-DRB1*07:01 confirmed as risk factor for lapatinib-induced liver damage

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Nirsevimab (Beyfortus) may reduce severe respiratory syncytial virus infections among infants
  • An artificial intelligence (AI) tool achieved high diagnostic accuracy for the identification and prediction of sepsis
  • Use of long-acting broadly neutralizing antibodies may delay human immunodeficiency virus (HIV) rebound following discontinuation of antiretroviral therapy
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.